Treatment with GQ-ODN has demonstrated inhibition of STAT3 and tumor growth in in vivo models of head and neck squamous cell carcinoma (HNSCC) [94], breast cancer, prostate cancer [93], and non-small cell lung cancer (NSCLC) [95]. The gene discussed is STAT3; the disease is head and neck squamous cell carcinoma.